KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Non-Current Debt: 2018-2025

Historic Non-Current Debt for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $4.0 billion.

  • Elanco Animal Health's Non-Current Debt fell 8.14% to $4.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year decrease of 8.14%. This contributed to the annual value of $4.3 billion for FY2024, which is 25.44% down from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Non-Current Debt is $4.0 billion, which was down 4.48% from $4.1 billion recorded in Q2 2025.
  • Elanco Animal Health's Non-Current Debt's 5-year high stood at $6.3 billion during Q3 2021, with a 5-year trough of $4.0 billion in Q3 2025.
  • Moreover, its 3-year median value for Non-Current Debt was $5.5 billion (2024), whereas its average is $5.0 billion.
  • As far as peak fluctuations go, Elanco Animal Health's Non-Current Debt skyrocketed by 172.95% in 2021, and later declined by 26.52% in 2024.
  • Over the past 5 years, Elanco Animal Health's Non-Current Debt (Quarterly) stood at $6.0 billion in 2021, then dropped by 9.58% to $5.4 billion in 2022, then increased by 5.29% to $5.7 billion in 2023, then declined by 25.44% to $4.3 billion in 2024, then decreased by 8.14% to $4.0 billion in 2025.
  • Its last three reported values are $4.0 billion in Q3 2025, $4.1 billion for Q2 2025, and $4.4 billion during Q1 2025.